Wiksten, J-P <br/><br/>
High tissue expression of tumour-associated trypsin inhibitor (TATI) associates with a more favourable prognosis in gastric cancer.  [electronic resource] 

 -  Histopathology  Apr 2005 
 - 380-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0309-0167 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2559.2005.02073.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--metabolism<br/>Aged<br/>Analysis of Variance<br/>Chi-Square Distribution<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Immunohistochemistry<br/>Male<br/>Neoplasm Staging<br/>Prognosis<br/>Stomach Neoplasms--metabolism<br/>Survival Analysis<br/>Trypsin Inhibitor, Kazal Pancreatic--biosynthesis